Legal Advantage Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,965
| Closed | -$1.8M | – | 104 |
|
|
2024
Q4 | $1.8M | Sell |
19,965
-600
| -3% | -$54K | 0.95% | 35 |
|
|
2024
Q3 | $2.03M | Sell |
20,565
-550
| -3% | -$54.3K | 1.12% | 29 |
|
|
2024
Q2 | $1.96M | Sell |
21,115
-400
| -2% | -$37.1K | 1.13% | 31 |
|
|
2024
Q1 | $2.04M | Sell |
21,515
-375
| -2% | -$35.6K | 1.14% | 28 |
|
|
2023
Q4 | $1.95M | Hold |
21,890
| – | – | 1.17% | 25 |
|
|
2023
Q3 | $1.6M | Sell |
21,890
-700
| -3% | -$51.1K | 1.14% | 25 |
|
|
2023
Q2 | $1.88M | Hold |
22,590
| – | – | 1.25% | 24 |
|
|
2023
Q1 | $1.72M | Buy |
22,590
+130
| +0.6% | +$9.91K | 1.26% | 24 |
|
|
2022
Q4 | $1.86M | Buy |
22,460
+115
| +0.5% | +$9.55K | 1.53% | 21 |
|
|
2022
Q3 | $1.77M | Buy |
22,345
+690
| +3% | +$54.7K | 1.66% | 18 |
|
|
2022
Q2 | $1.61M | Buy |
21,655
+1,245
| +6% | +$92.4K | 1.57% | 19 |
|
|
2022
Q1 | $1.83M | Hold |
20,410
| – | – | 1.38% | 26 |
|
|
2021
Q4 | $2.29M | Sell |
20,410
-470
| -2% | -$52.6K | 1.55% | 20 |
|
|
2021
Q3 | $2.63M | Buy |
20,880
+600
| +3% | +$75.4K | 1.76% | 19 |
|
|
2021
Q2 | $2.75M | Hold |
20,280
| – | – | 1.88% | 17 |
|
|
2021
Q1 | $2.75M | Buy |
20,280
+100
| +0.5% | +$13.6K | 2.06% | 16 |
|
|
2020
Q4 | $2.84M | Buy |
+20,180
| New | +$2.84M | 2.21% | 15 |
|